Study identifier:D133FR00226
ClinicalTrials.gov identifier:NCT07617636
EudraCT identifier:N/A
CTIS identifier:N/A
Artificial Intelligence for the Analysis of STAS and lung cancer risk stratification
lung cancer
N/A
No
-
All
1500
Observational
50 Years - 80 Years
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jun 2026 by AstraZeneca
AstraZeneca
-
No locations available
| Arms | Assigned Interventions |
|---|